Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Elad Kedar
Advertisement
Articles by Elad Kedar
Orasis Pharmaceuticals drop in development for treating presbyopia
Advertisement
Latest Updated Articles
Pipeline: Presbyopia treatment to finish Phase 3 late 2021Published: June 4th 2021 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
A preview into advances in optometry at EnVision Summit 2026
2
No myopia progression reported on average in 6-month trial assessing MiYOSMART iQ spectacle lenses
3
Some red light therapy devices may exceed safety levels for myopia control, study suggests
4
What to know about the most recent treatment and management developments in AMD
5